OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
GRIN.CD57

Grown Rogue International Inc

PharmaceuticalsVerified

Grown Rogue International Inc has a liquidity position that is medium in risk, with a current ratio of 3.87, indicating the company can cover its short-term liabilities more than three times over. The company's cash and equivalents amount to $11,371,830, while its long-term debt is $12,816,010, resulting in a net cash position that is negative after subtracting total debt. The debt-to-equity ratio of 0.61 suggests a moderate level of leverage, with total liabilities of $41,833,320 and total equity of $20,903,210. In terms of profitability, Grown Rogue International Inc reported a gross profit of $14,146,690 on revenue of $32,427,940, yielding a gross margin of 43.63%. However, the company's operating income was negative at -$593,480, indicating that operating expenses exceeded gross profit. The return on equity (ROE) of 8.28% and return on assets (ROA) of 2.76% suggest that the company is generating a modest return for shareholders and assets. The company's revenue is primarily concentrated in the United States, with operations in Oregon, Michigan, and New Jersey, and under development in Illinois. No specific segment or geographic revenue breakdown is provided in the available data, but the company's focus on premium flower and flower-derived products suggests a concentration in the craft cannabis market. Looking at the company's growth trajectory, the available data does not provide forward-looking revenue projections or outlooks for the current or next fiscal year. The company's capital expenditure of -$4,659,010 indicates a significant outflow for investments in infrastructure or operations. The free cash flow of -$726,790 suggests that the company is not generating sufficient cash from operations to cover its capital expenditures. The risk assessment for Grown Rogue International Inc indicates a medium liquidity risk and a low dilution risk. The company's liquidity risk is primarily due to its negative net cash position after subtracting total debt. The dilution risk is low, suggesting that the company is not expected to issue additional shares in the near term. The company's operating cash flow of $3,569,800 indicates that it is generating positive cash from operations, which is a positive sign for liquidity. Recent events and filings for Grown Rogue International Inc are not detailed in the provided data, but the company's operations in multiple states and its focus on premium cannabis products suggest that it is navigating a complex regulatory and competitive landscape. The company's financial performance and strategic initiatives will be critical in determining its future success in the cannabis industry.

30-day price · GRIN.CD+0.06 (+14.3%)
Low$0.39High$0.63Close$0.48As of15 May, 00:00 UTC
Profile
CompanyGrown Rogue International Inc
TickerGRIN.CD
SectorHealthcare
BusinessPharmaceuticals & Medical Research
Industry groupPharmaceuticals & Medical Research
IndustryPharmaceuticals
AI analysis

Business. Grown Rogue International Inc is a craft cannabis company operating in Oregon, Michigan, and New Jersey, with development underway in Illinois, focused on providing premium flower and flower-derived products.

Classification. Grown Rogue International Inc is classified under the Healthcare sector, specifically in the Pharmaceuticals & Medical Research business sector, with a confidence level of 0.92.

Grown Rogue International Inc has a liquidity position that is medium in risk, with a current ratio of 3.87, indicating the company can cover its short-term liabilities more than three times over. The company's cash and equivalents amount to $11,371,830, while its long-term debt is $12,816,010, resulting in a net cash position that is negative after subtracting total debt. The debt-to-equity ratio of 0.61 suggests a moderate level of leverage, with total liabilities of $41,833,320 and total equity of $20,903,210. In terms of profitability, Grown Rogue International Inc reported a gross profit of $14,146,690 on revenue of $32,427,940, yielding a gross margin of 43.63%. However, the company's operating income was negative at -$593,480, indicating that operating expenses exceeded gross profit. The return on equity (ROE) of 8.28% and return on assets (ROA) of 2.76% suggest that the company is generating a modest return for shareholders and assets. The company's revenue is primarily concentrated in the United States, with operations in Oregon, Michigan, and New Jersey, and under development in Illinois. No specific segment or geographic revenue breakdown is provided in the available data, but the company's focus on premium flower and flower-derived products suggests a concentration in the craft cannabis market. Looking at the company's growth trajectory, the available data does not provide forward-looking revenue projections or outlooks for the current or next fiscal year. The company's capital expenditure of -$4,659,010 indicates a significant outflow for investments in infrastructure or operations. The free cash flow of -$726,790 suggests that the company is not generating sufficient cash from operations to cover its capital expenditures. The risk assessment for Grown Rogue International Inc indicates a medium liquidity risk and a low dilution risk. The company's liquidity risk is primarily due to its negative net cash position after subtracting total debt. The dilution risk is low, suggesting that the company is not expected to issue additional shares in the near term. The company's operating cash flow of $3,569,800 indicates that it is generating positive cash from operations, which is a positive sign for liquidity. Recent events and filings for Grown Rogue International Inc are not detailed in the provided data, but the company's operations in multiple states and its focus on premium cannabis products suggest that it is navigating a complex regulatory and competitive landscape. The company's financial performance and strategic initiatives will be critical in determining its future success in the cannabis industry.
Key takeaways
  • Grown Rogue International Inc has a current ratio of 3.87, indicating strong short-term liquidity.
  • The company's gross margin of 43.63% is a positive indicator of cost control and pricing power.
  • The company's operating income is negative at -$593,480, suggesting that operating expenses exceed gross profit.
  • The company's debt-to-equity ratio of 0.61 indicates a moderate level of leverage.
  • The company's free cash flow is negative at -$726,790, indicating that it is not generating sufficient cash from operations to cover its capital expenditures.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$32.4M
Gross profit$14.1M
Operating income-$593.5k
Net income$1.7M
R&D
SG&A
D&A
SBC
Operating cash flow$3.6M
CapEx-$4.7M
Free cash flow-$726.8k
Total assets$62.7M
Total liabilities$41.8M
Total equity$20.9M
Cash & equivalents$11.4M
Long-term debt$12.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$20.9M
Net cash-$1.4M
Current ratio3.9
Debt/Equity0.6
ROA2.8%
ROE8.3%
Cash conversion2.1%
CapEx/Revenue-14.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals & Medical Research · cohort 1 companies
MetricGRIN.CDActivity
Op margin-1.8%-2.9% medp25 -218.9% · p75 9.6%above median
Net margin5.3%28.2% medp25 28.2% · p75 28.2%bottom quartile
Gross margin43.6%47.8% medp25 27.6% · p75 68.9%below median
CapEx / revenue-14.4%6.6% medp25 6.6% · p75 6.6%bottom quartile
Debt / equity61.0%271.5% medp25 271.5% · p75 271.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:22 UTC#eae083e2
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 08:25 UTCJob: 58b68b03